Dissecting the Genetic Susceptibility to Graves' Disease in a Cohort of Patients of Italian Origin.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 27014188)

Published in Front Endocrinol (Lausanne) on March 08, 2016

Authors

Angela Lombardi1, Francesca Menconi2, David Greenberg3, Erlinda Concepcion1, Marenza Leo2, Roberto Rocchi2, Michele Marinó2, Mehdi Keddache4, Yaron Tomer5

Author Affiliations

1: Division of Endocrinology, Icahn School of Medicine at Mount Sinai , New York, NY , USA.
2: Endocrinology, University Hospital of Pisa , Pisa , Italy.
3: Battelle Center for Mathematical Medicine, Nationwide Children's Hospital , Columbus, OH , USA.
4: Cincinnati Children's Hospital Medical Center , Cincinnati, OH , USA.
5: Division of Endocrinology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Bronx VA Medical Center, Bronx, NY, USA.

Articles cited by this

Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23

On estimating the relation between blood group and disease. Ann Hum Genet (1955) 26.39

Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab (2002) 13.06

A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet (2006) 6.98

Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered (2008) 5.89

The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet (1996) 3.37

Common Kibra alleles are associated with human memory performance. Science (2006) 3.30

Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol (Oxf) (2007) 3.17

Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcription. Science (2013) 2.66

Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev (2003) 2.23

Basic statistical analysis in genetic case-control studies. Nat Protoc (2011) 1.86

A population-based study of Graves' disease in Danish twins. Clin Endocrinol (Oxf) (1998) 1.67

Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet (1997) 1.65

The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun (2008) 1.61

CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab (1995) 1.49

Genetic-epigenetic dysregulation of thymic TSH receptor gene expression triggers thyroid autoimmunity. Proc Natl Acad Sci U S A (2014) 1.45

A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid (2002) 1.41

Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study. Exp Clin Endocrinol Diabetes (2006) 1.40

CTLA-4 and its role in autoimmune thyroid disease. J Mol Endocrinol (2003) 1.33

Long-range DNA looping and gene expression analyses identify DEXI as an autoimmune disease candidate gene. Hum Mol Genet (2011) 1.29

The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun (2007) 1.25

A study of human leukocyte D locus related antigens in Graves' disease. J Clin Invest (1979) 1.21

Efnb1 and Efnb2 proteins regulate thymocyte development, peripheral T cell differentiation, and antiviral immune responses and are essential for interleukin-6 (IL-6) signaling. J Biol Chem (2011) 1.21

Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis. J Autoimmun (2007) 1.18

Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab (2007) 1.14

Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Proc Natl Acad Sci U S A (2008) 1.08

The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. J Autoimmun (2009) 1.07

Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases? Autoimmun Rev (2014) 1.05

Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases: a meta-analysis. Endocrine (2012) 1.04

Immune mechanisms in autoimmune thyroiditis. Adv Immunol (1989) 1.03

The genetic basis of autoantibody production. Autoimmun Rev (2005) 1.03

Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet (2000) 1.03

Fine mapping of loci linked to autoimmune thyroid disease identifies novel susceptibility genes. J Clin Endocrinol Metab (2012) 1.01

Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease. J Clin Endocrinol Metab (2000) 0.99

Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid (2001) 0.97

CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid (2005) 0.97

Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J Clin Endocrinol Metab (2000) 0.95

Vitamin D deficiency in patients with Graves' disease: probably something more than a casual association. Endocrine (2012) 0.95

Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies. J Clin Immunol (2012) 0.93

Application of the Linux cluster for exhaustive window haplotype analysis using the FBAT and Unphased programs. BMC Bioinformatics (2008) 0.88

Ethnic differences in the clinical presentation of Graves' ophthalmopathy. Best Pract Res Clin Endocrinol Metab (2012) 0.87

Association of Graves' disease with intragenic polymorphism of the thyrotropin receptor gene in a cohort of Singapore patients of multi-ethnic origins. Thyroid (2003) 0.87

Genetic analysis in young-age-of-onset Graves' disease reveals new susceptibility loci. J Clin Endocrinol Metab (2014) 0.87

The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans. J Clin Endocrinol Metab (2000) 0.86

Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population. Horm Res (2005) 0.86

Current Insights into the Pathogenesis of Graves' Ophthalmopathy. Horm Metab Res (2015) 0.84

Preliminary evidence of genetic anticipation in Graves' disease. Thyroid (2003) 0.84

Role of genetic and non-genetic factors in the etiology of Graves' disease. J Endocrinol Invest (2014) 0.84

Does GRK-β arrestin machinery work as a "switch on" for GPR17-mediated activation of intracellular signaling pathways? Cell Signal (2014) 0.83

Association of Fc receptor-like 5 (FCRL5) with Graves' disease is secondary to the effect of FCRL3. Clin Endocrinol (Oxf) (2010) 0.83

HLA class II alleles in Japanese patients with Graves' disease: weak associations of HLA-DR and -DQ. Endocr J (1994) 0.81

Trauma and pressure explain the clinical presentation of the Graves' disease triad. Thyroid (2000) 0.81

The association of thyroid peroxidase antibody risk loci with susceptibility to and phenotype of Graves' disease. Clin Endocrinol (Oxf) (2014) 0.80

Role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy: the hypothesis of Kriss revisited. J Endocrinol Invest (2004) 0.80

Self-reactive CD4+ T cells and B cells in the blood in health and autoimmune disease: increased frequency of thyroglobulin-reactive cells in Graves' disease. J Clin Immunol (2006) 0.80

Association of BTG2, CYR61, ZFP36, and SCD gene polymorphisms with Graves' disease and ophthalmopathy. Thyroid (2014) 0.80

Novel single-nucleotide polymorphisms in the calsequestrin-1 gene are associated with Graves' ophthalmopathy and Hashimoto's thyroiditis. Clin Ophthalmol (2015) 0.79

Genetic variations in the SOCS3 gene in patients with Graves' ophthalmopathy. J Clin Pathol (2015) 0.79

A novel feedback mechanism by Ephrin-B1/B2 in T-cell activation involves a concentration-dependent switch from costimulation to inhibition. Eur J Immunol (2012) 0.78

RNA sequencing identifies upregulated kyphoscoliosis peptidase and phosphatidic acid signaling pathways in muscle hypertrophy generated by transgenic expression of myostatin propeptide. Int J Mol Sci (2015) 0.78

Genetic association between IL-17F gene polymorphisms and the pathogenesis of Graves' Disease in the Han Chinese population. Gene (2012) 0.78

Dense mapping of IL2RA shows no association with Graves' disease in Chinese Han population. Clin Endocrinol (Oxf) (2013) 0.77

Association of TLR4 and TLR5 gene polymorphisms with Graves' disease in Chinese Cantonese population. Hum Immunol (2014) 0.77

CTLA-4 gene and the susceptibility of multiple sclerosis: an updated meta-analysis study including 12,916 cases and 15,455 controls. J Neurogenet (2014) 0.77

Endoplasmic reticulum stress as a novel mechanism in amiodarone-induced destructive thyroiditis. J Clin Endocrinol Metab (2015) 0.77

Autoimmune thyroid disease susceptibility loci in a large Chinese family. Clin Endocrinol (Oxf) (2002) 0.77

HMGN2, a new anti-tumor effector molecule of CD8⁺ T cells. Mol Cancer (2014) 0.76

Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves' ophthalmopathy: a review. Clin Ophthalmol (2015) 0.76

HLA study on two Mexican Mestizo families with autoimmune thyroid disease. Autoimmunity (2002) 0.76